کد مقاله | کد نشریه | سال انتشار | مقاله انگلیسی | نسخه تمام متن |
---|---|---|---|---|
2154984 | 1090272 | 2006 | 11 صفحه PDF | دانلود رایگان |

IntroductionSince the demand for 18F-fluorinated peptides for quantitative in vivo receptor imaging using PET has increased, a new chemoselective two-step 18F-labeling strategy based on hydrazone formation between an unprotected hydrazine-functionalized peptide and an 18F-labeled aldehyde was developed.MethodsFirst, 4-[18F]fluorobenzaldehyde ([18F]FB-CHO) was prepared from 4-formyl-N,N,N-trimethylanilinium triflate via direct no-carrier-added 18F-fluorination (dimethyl sulfoxide, 90°C, 5 min) and purified by RP-HPLC. Hydrazone formation between [18F]FB-CHO and 6-hydrazinonicotinic acid (HYNIC) and the unprotected HYNIC-functionalized peptides (HYNIC-d-Phe1)-Tyr3-Thr8-octreotide and (HYNIC-Arg1)-substance P was evaluated with respect to the dependence of radiochemical yield on pH, precursor concentration and temperature. The stability of [18F]FB-CH=N-HYNIC-Tyr3-Thr8(NH2)-octreotide in aqueous solution at various pH (4.0, 5.5 and 7.5) as well as the in vivo stability of [18F]FB-CH=N-HYNIC-Tyr3-Thr8-octreotide in mouse blood (30 min p.i.) was investigated.ResultsYields of the hydrazone formation were independent of pH between pH 0.5 and 5.5. Optimal labeling yields of 85% were obtained with a precursor concentration of 2.1 mM at 70°C for 10 min. The labeling products were stable at pH 7.5 at 37°C, while in more acidic media (pH 4.0) the product slowly decomposed to form up to 31±2% [18F]FB-CHO within 5 h. Metabolite studies showed no detectable degradation of [18F]FB-CH=N-HYNIC-Tyr3-Thr8-octreotide in mouse blood (30 min p.i.).ConclusionsIn conclusion, chemoselective hydrazone formation between unprotected HYNIC-functionalized peptides and [18F]FB-CHO is a fast and straightforward radiolabeling method leading to high yields under mild acidic conditions. In addition, it represents a powerful and versatile radiolabeling strategy that is applicable to a variety of radionuclides and peptide precursors already available for 99mTc labeling.
Journal: Nuclear Medicine and Biology - Volume 33, Issue 2, February 2006, Pages 173–183